{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:10:51Z","timestamp":1793437851561,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007659","name":"Bayer Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jcmg.2026.08.005","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T11:52:52Z","timestamp":1788090772000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["124Iodine Evuzamitide Positron Emission Tomography in Patients With Established or Suspected Cardiac Amyloidosis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6390-6526","authenticated-orcid":false,"given":"Ahmad","family":"Masri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israt","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrick","family":"Gillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Alqabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austen","family":"Suits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryton","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica T.","family":"Mejia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Raposo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maros","family":"Ferencik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Medvedova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Mallak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmg.2026.08.005_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.14797\/mdcvj.1061","article-title":"Clinical clues and diagnostic workup of cardiac amyloidosis","volume":"18","author":"Gill","year":"2022","journal-title":"Methodist DeBakey Cardiovasc J"},{"key":"10.1016\/j.jcmg.2026.08.005_bib2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.mayocp.2018.08.041","article-title":"Incidence of AL amyloidosis in Olmsted County, Minnesota, 1990 through 2015","volume":"94","author":"Kyle","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jcmg.2026.08.005_bib3","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonzalez-Lopez","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2026.08.005_bib4","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/jamacardio.2021.3070","article-title":"Prevalence of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction","volume":"6","author":"AbouEzzeddine","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcmg.2026.08.005_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12350-019-01761-5","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 2 of 2-Diagnostic criteria and appropriate utilization","volume":"27","author":"Dorbala","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2026.08.005_bib6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/13506129.2025.2553525","article-title":"A cautionary case series: tafamidis mistreatment following erroneous diagnosis of transthyretin cardiac amyloidosis","volume":"32","author":"Muchtar","year":"2025","journal-title":"Amyloid"},{"key":"10.1016\/j.jcmg.2026.08.005_bib7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jcmg.2025.03.014","article-title":"Uncertain clinical relevance of serial bone scintigraphy findings in treated transthyretin amyloid cardiomyopathy","volume":"18","author":"Razvi","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.08.005_bib8","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s12350-019-01935-1","article-title":"The current status of quantitative SPECT\/CT in the assessment of transthyretin cardiac amyloidosis","volume":"27","author":"Ramsay","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2026.08.005_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1200\/JCO-25-02558","article-title":"New validated staging system for light chain (AL) amyloidosis with stage IIIC defining ultra-poor risk: AL international staging system","volume":"44","author":"Khwaja","year":"2026","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcmg.2026.08.005_bib10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jacc.2025.09.004","article-title":"Transthyretin cardiac amyloidosis evaluation and management: 2025 ACC concise clinical guidance","volume":"87","author":"Kittleson","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2026.08.005_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41408-024-01040-8","article-title":"Timing and co-occurrence of symptoms prior to a diagnosis of light chain (AL) amyloidosis","volume":"14","author":"Singh","year":"2024","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jcmg.2026.08.005_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11936-024-01049-z","article-title":"Advances in diagnosis and treatment of AL cardiac amyloidosis","volume":"26","author":"Sapru","year":"2024","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.jcmg.2026.08.005_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00259-023-06381-3","article-title":"Positron emission tomography in the diagnosis and follow-up of transthyretin amyloid cardiomyopathy patients: a systematic review","volume":"51","author":"Tingen","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jcmg.2026.08.005_bib14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jcmg.2025.01.018","article-title":"Early detection of transthyretin cardiac amyloidosis using (124)I-Evuzamitide positron emission tomography\/computed tomography","volume":"18","author":"Smiley","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.08.005_bib15","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcmg.2023.07.007","article-title":"Cardiac amyloid quantification using 124I-evuzamitide (124I-P5+14) versus 18F-florbetapir: a pilot PET\/CT study","volume":"16","author":"Clerc","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.08.005_bib16","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jcmg.2023.08.009","article-title":"Cardiac amyloid detection by PET\/CT imaging of iodine (124I) evuzamitide (124I-p5+14): a phase 1\/2 study","volume":"16","author":"Wall","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.08.005_bib17","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2026.08.005_bib18","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2026.08.005_bib19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jaccao.2024.12.005","article-title":"A multicenter study of contemporary long-term tafamidis outcomes in transthyretin amyloid cardiomyopathy","volume":"7","author":"Masri","year":"2025","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jcmg.2026.08.005_bib20","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jcmg.2019.10.015","article-title":"Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis","volume":"13","author":"Musumeci","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.08.005_bib21","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221082","article-title":"99mTc bone-avid tracer cardiac scintigraphy: role in noninvasive diagnosis of transthyretin cardiac amyloidosis","volume":"306","author":"Khor","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.jcmg.2026.08.005_bib22","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jcmg.2025.06.005","article-title":"Cardiac magnetic resonance-based tissue characterization for detection of transthyretin cardiac amyloidosis with negative or equivocal technetium-pyrophosphate scan","volume":"18","author":"Subashchandran","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.08.005_bib23","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1093\/eurheartj\/ehaf531","article-title":"Cardiac magnetic resonance imaging in transthyretin amyloidosis: getting to the heart of the matter","volume":"46","author":"Masri","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2026.08.005_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2026.102773","article-title":"Design and rationale of the research with EVuzamitide to evaluate for cardiac AmyLoidosis (REVEAL) positron emission tomography study: a study of 124I-evuzamitide to diagnose cardiac amyloidosis","volume":"61","author":"Dorbala","year":"2026","journal-title":"J Nucl Cardiol"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X26004390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X26004390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:01:56Z","timestamp":1790280116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X26004390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":24,"alternative-id":["S1936878X26004390"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2026.08.005","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"124Iodine Evuzamitide Positron Emission Tomography in Patients With Established or Suspected Cardiac Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2026.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}